Nicolas Guyon-Gellin

Nicolas Guyon-Gellin (M.D., MSc) brings Calypso Biotech more than 10 years of expertise in global Healthcare financial markets as an equity research analyst for Morgan Stanley London, Exane BNP and Amundi Paris and 5 years of Biotech Business Development and Strategy expertise for ENYO Pharma.

Dr Guyon-Gellin has received his M.D. from Université Paris Descartes (Paris V) as a General Practitioner and Master degree (MSc) from ESCP Europe.